Zdrowie i gospodarka · 29/09/2021
FDA Announces Draft Guidance for Developing Drugs to Treat Nontuberculous Mycobacterial Pulmonary Disease
The FDA is releasing a draft guidance to help pharmaceutical companies develop treatments for nontuberculous mycobacterial pulmonary disease caused by Mycobacterium avium complex.